HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.

Euroasian J Hepatogastroenterol · 2021 · PMC8566153 · PMID 34786358

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.1300

boldest claim

The sentences

highly significantp <0.001actually significant

Differences were considered statistically significant ( p <0.05), very significant ( p <0.01), or highly significant ( p <0.001).

also in 132,142 other papers

a nonsignificant trendp = 0.13not close (p > 0.1)

The comparison between days 0 and 4 only showed a nonsignificant trend in the same analysis in favor of the control group (TLR3, p = 0.13; TLR7, p = 0.06; and TLR8, p = 0.13).

also in 5,406 other papers

an important trendno p-value reported

In the analysis at day 8th, an important trend was detected both in proportions and fluorescence mean; however, the differences were not statistically significant ( p >0.05) as shown in Figure 3 .

also in 1,052 other papers

an increasing trendno p-value reported

There was an increasing trend in frequency and fluorescence mean at day 8, but no significant differences as in the case of monocytes.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.